InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
U0126 | Cysteine-rich protein 2 deficiency attenuates angiotensin II-induced abdomina... | 2022 | J Biomed Sci. | Chen C.H. et al. | DOI: 10.1186/s12929-022-00808-z |
Primocin® | Organoid-based expansion of patient-derived primary alveolar type 2 cells for... | 2022 | Am J Physiol Lung Cell Mol Physiol. | Van Riet S. et al. | DOI: 10.1152/ajplung.00153.2021 |
Primocin® | Brown adipose tissue involution associated with progressive restriction in pr... | 2022 | Cell Rep | Huang Z. et al. | DOI: 10.1016/j.celrep.2022.110575 |
Blasticidin | Brown adipose tissue involution associated with progressive restriction in pr... | 2022 | Cell Rep | Huang Z. et al. | DOI: 10.1016/j.celrep.2022.110575 |
Human IL-1α & IL-1β Reporter HEK 293 Cells | Resurrection of an ancient inflammatory locus reveals switch to caspase-1 spe... | 2022 | J Biol Chem. | Bibo-Verdugo B. et al. | DOI: 10.1016/j.jbc.2022.101931 |
QUANTI-Blue™ | Resurrection of an ancient inflammatory locus reveals switch to caspase-1 spe... | 2022 | J Biol Chem. | Bibo-Verdugo B. et al. | DOI: 10.1016/j.jbc.2022.101931 |
Normocin® - Antimicrobial Reagent | Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold. | 2022 | ACS Chem Biol. | Weidenbacher P.A. et al. | DOI: 10.1021/acschembio.2c00140 |
QUANTI-Blue™ | Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold. | 2022 | ACS Chem Biol. | Weidenbacher P.A. et al. | DOI: 10.1021/acschembio.2c00140 |
RAW-Blue™ Cells | Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold. | 2022 | ACS Chem Biol. | Weidenbacher P.A. et al. | DOI: 10.1021/acschembio.2c00140 |
Zeocin® | Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold. | 2022 | ACS Chem Biol. | Weidenbacher P.A. et al. | DOI: 10.1021/acschembio.2c00140 |
Pam3CSK4 | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
Blasticidin | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
TL8-506 | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
R848 (Resiquimod) | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
293XL/TLR7 | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
QUANTI-Blue™ | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
Poly(I:C) HMW | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
Human TLR8 Reporter HEK293 Cells (NF-κB) | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
293XL/TLR8 | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |
Zeocin® | TLR8 is activated by 5'-methylthioinosine, a Plasmodium falciparum-derived in... | 2022 | Cell Rep. | Köllisch G. et al. | DOI: 10.1016/j.celrep.2022.110691 |